Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, which appears to be a minor system update with no changes to core page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe Publications section now notes that publications are provided voluntarily and are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded the study site entry: Tainan, Taiwan 704. Removed the previous listing 'Tainan City, Taiwan 704' and removed the government funding status notice.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study status changed from Active, not recruiting to Completed (as of 2025-10-29).SummaryDifference0.3%

- Check50 days agoChange DetectedAdded Cali, Colombia, 760001 as a study site and removed Santiago de Cali, Colombia, 760001 from the Locations section.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page has been updated to add new registry identifiers, recent dates, and new trial data access links while removing older dates and legacy EngageZone links.SummaryDifference0.7%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.